SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 97.00 |
| Enterprise Value ($M) | 118.07 |
| Book Value ($M) | 82.79 |
| Book Value / Share | 1.29 |
| Price / Book | 1.17 |
| NCAV ($M) | 80.36 |
| NCAV / Share | 1.25 |
| Price / NCAV | 1.21 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.74 |
| Return on Assets (ROA) | -0.48 |
| Return on Equity (ROE) | -0.69 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.68 |
| Current Ratio | 7.68 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 140.94 |
| Assets | 143.36 |
| Liabilities | 60.57 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Affinity Asset Advisors, LLC | 6.18 | ||
| 13G/A | Eventide Asset Management, Llc | 6.44 | 30.02 | |
| 13G | BlackRock, Inc. | 5.60 | 0.00 | |
| 13D/A | Sofinnova Venture Partners X, L.P. | 6.90 | 111.03 | |
| 13G | Samlyn Capital, Llc | 5.50 | ||
| 13G/A | New Enterprise Associates 15, L.P. | |||
| 13G/A | Venrock Healthcare Capital Partners II, L.P. | 0.00 | -100.00 | |
| 13G/A | Rock Springs Capital Management LP | 5.96 | 19.29 | |
| 13G/A | Deep Track Capital, LP | 0.00 | -100.00 | |
| 13G/A | Baker Bros. Advisors Lp | 0.00 | -100.00 | |
| 13D/A | Pivotal bioVenture Partners Fund I, L.P. | 7.20 | 0.00 | |
| 13G/A | Adage Capital Partners Gp, L.l.c. | 8.97 | 78.62 | |
| 13G/A | Sphera Funds Management Ltd. | 2.53 | -25.44 | |
| 13G/A | Millennium Management Llc | 1.50 | -60.25 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 219,026 | 1,071,291 | 20.45 | |
| 304,530 | 1,451,006 | 20.99 | |
| 265,214 | 1,451,818 | 18.27 | |
| 284,438 | 2,144,450 | 13.26 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| INNV – InnovAge Holding Corp. | INSM – Insmed Incorporated |
| INVA – Innoviva, Inc. | IOBT – IO Biotech, Inc. |
| IONS – Ionis Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io